Floatz logo

dt-7012

Sezary Syndrome

Assistance Publique - Hôpitaux de Parismonoclonal_antibodyEarly Phase 1Active
C
38/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
81/ 100

Competitive context

21 Active assets in the Sezary Syndrome cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Shanghai Jiao Tong University School of Medicine
Phase 4BB
PREDNISONE TABLETS
Shanghai Jiao Tong University School of Medicine
Phase 4BB
(+)-VINCRISTINE
Shanghai Jiao Tong University School of Medicine
Phase 4BB
CYCLOSPORIN A
Ohio State University Comprehensive Cancer Center
Phase 2BB
Denileukin Diftitox
Eisai Inc.
Phase 4B

View all 40 →

Same molecule, other indications

dt-7012 is also rated in:

cancerDormant
CC
Indicative ·
40 / 100
View asset →
primary cutaneous T-cell non-Hodgkin lymphomaDormant
C
Indicative ·
39 / 100
View asset →
mycosis fungoidesDormant
C
Indicative ·
38 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →